Picture of Qiagen NV logo

QGEN Qiagen NV News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapNeutral

Brief: QIAGEN And Myriad Genetics Develop Distributable Homologous Recombination Deficiency Test

May 31 (Reuters) - QIAGEN NV  QIA.DE :
    * SAID ON THURSDAY: QIAGEN AND MYRIAD GENETICS DEVELOP
DISTRIBUTABLE HOMOLOGOUS RECOMBINATION DEFICIENCY TEST FOR
GLOBAL RESEARCH AND COMPANION DIAGNOSTICS APPLICATIONS

    
 Further company coverage:  QIA.DE  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Qiagen NV

See all news